A Katten team represented PRISM Vision Group, LLC (PRISM) in its acquisition by McKesson Corporation (NYSE: MCK). PRISM signed a definitive agreement earlier this week to sell an 80 percent controlling interest to McKesson Corporation for approximately $850 million, with PRISM physicians and management retaining a 20 percent stake.
The Katten team was led by Corporate Partners Roger Griesmeyer and Dilen Kumar, and included Associates Jesse O'Connell, Julie Park, Alex Lindsey, Astoneia Moss and Miriam Wang; Health Care Partner Ramana Rameswaran; and Transactional Tax Planning Partner Valentina Famparska.
"McKesson Advances Specialty Leadership; Signs Agreement to Acquire Controlling Interest in PRISM Vision Holdings, LLC," McKesson.com, February 4, 2025
"McKesson (MCK) to Acquire Controlling Interest in PRISM Vision Holdings, LLC," StreetInsider.com, February 4, 2025